TP63 Gene ADULT Syndrome Split Hand-Foot Malformation Genetic Test
Test Name: TP63 Gene ADULT Syndrome Split Hand-Foot Malformation Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TP63 Gene ADULT Syndrome, Split Hand-Foot Malformation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene ADULT Syndrome, Split Hand-Foot Malformation NGS Genetic DNA Test gene TP63
Test Details:
ADULT syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This gene provides instructions for making a protein called p63, which plays a crucial role in the development of many tissues and organs, including the skin, limbs, and face. One of the main features of ADULT syndrome is split hand-foot malformation (SHFM), which is characterized by the absence or malformation of certain fingers or toes. People with ADULT syndrome may have missing digits, fused digits, or other abnormalities in their hands and feet.
NGS genetic testing, also known as next-generation sequencing, is a powerful tool used to identify mutations in genes. It allows for the simultaneous sequencing of multiple genes, including the TP63 gene, in a faster and more cost-effective manner compared to traditional sequencing methods. By analyzing a person’s DNA sample, NGS genetic testing can detect mutations in the TP63 gene associated with ADULT syndrome. This can help confirm a diagnosis and provide valuable information for genetic counseling, family planning, and potential treatment options.
It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support based on the test results.
| Test Name | TP63 Gene ADULT syndrome split hand-foot malformation Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TP63 Gene ADULT syndrome, split hand-foot malformation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene ADULT syndrome, split hand-foot malformation NGS Genetic DNA Test gene TP63 |
| Test Details | ADULT syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This gene provides instructions for making a protein called p63, which plays a crucial role in the development of many tissues and organs, including the skin, limbs, and face. One of the main features of ADULT syndrome is split hand-foot malformation (SHFM), which is characterized by the absence or malformation of certain fingers or toes. People with ADULT syndrome may have missing digits, fused digits, or other abnormalities in their hands and feet. NGS genetic testing, also known as next-generation sequencing, is a powerful tool used to identify mutations in genes. It allows for the simultaneous sequencing of multiple genes, including the TP63 gene, in a faster and more cost-effective manner compared to traditional sequencing methods. By analyzing a person’s DNA sample, NGS genetic testing can detect mutations in the TP63 gene associated with ADULT syndrome. This can help confirm a diagnosis and provide valuable information for genetic counseling, family planning, and potential treatment options. It is important to note that genetic testing should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support based on the test results. |
